News

Filter

All News Press Release Publications

South Rampart Pharma Achieves Development Milestone and Advances to Phase II of Active NIH Fast-Track STTR Commercialization Award

May 4, 2022

$1.9 million NIH fast-track STTR grant fuels next stage of clinical program dedicated to the…

South Rampart Pharma Appoints Robert Dickey, MBA, as Chief Financial Officer

March 31, 2022

Mr. Dickey brings over 25 years of experience as a CFO and COO in private,…

South Rampart Pharma Announces Patient Enrollment and Dosing Underway in Phase 1 Study Evaluating Novel Non-Opioid Approach to Pain with Lead Program, SRP-3D (DA)

March 23, 2022

SRP-3D (DA) has demonstrated a compelling safety profile over currently available pain medications Potential to…

South Rampart Pharma Invited to Participate in 2021 NIH Innovation Conference & Life Sciences Summit

August 20, 2021

NOLABA News - Exciting news for local company South Pharma! They've been selected to participate in…

LSU HSCNO Spin-Out Awarded $1.9M in STTR Fast Track Funding

September 28, 2020

NIH Awards $1.9 million STTR Grant to Fast Track New Class of Non-Opioid Pain Relievers

September 25, 2020

NIH STTR Grant To Fast Track New Class Of Pain Reliever Without Addiction Or Toxicity

September 25, 2020

The National Institute of Neurological Disorders and Stroke of the National Institutes of Health (NIH)…

Promising New Analgesic Offers Pain Relief Without Liver Toxicity

July 28, 2020

Novel Analgesic for Pain Relief Lacks Liver Toxicity

July 24, 2020

Researchers Find Alternatives for Acetaminophen Without Liver, Kidney Effects

July 20, 2020

South Rampart Pharma Identifies New Class of Non-Opioid Pain Medicines in European Journal of Medicinal Chemistry Publication

July 14, 2020

NEW ORLEANS, July 10, 2020 – South Rampart Pharma, LLC (“South Rampart” or “the Company”),…

South Rampart Pharma Identifies New Class of Non-Opioid Pain Medicines in European Journal of Medicinal Chemistry Publication

July 14, 2020

Research Roundup: COVID-19 Immunity, Stomach Acid Susceptibility and More

July 10, 2020

Researchers Developing Safer Version of Acetaminophen

July 8, 2020

Novel class of non-addictive analgesics demonstrate safety in animals

July 7, 2020

To overcome the issues of current analgesics, researchers reveal a new class of non-narcotic pipeline…

Team Synthesizes Safer Nonaddictive Analgesics

July 7, 2020

Researchers at LSU Health New Orleans Neuroscience Center of Excellence and colleagues have discovered a…

Safer Class of Painkillers Identified

July 7, 2020

They discover a new class of pain relievers that do not harm the liver or kidneys

July 7, 2020

A new class of pipeline drugs to relieve pain and reduce fever without the danger of addiction or damage

July 6, 2020

LSU Health New Orleans discovers new class of safer analgesics

July 6, 2020

New Orleans, LA - Researchers at LSU Health New Orleans Neuroscience Center of Excellence and…

LSU Health New Orleans Discovers New Class of Safer Analgesics

July 6, 2020

New class of safer analgesics discovered

July 6, 2020

A novel pipeline of 2-(benzenesulfonamide)-N-(4-hydroxyphenyl) acetamide analgesics that lack hepatotoxicity and retain antipyresis

June 30, 2020

European Journal of Medicinal Chemistry Sept 2020

© 2022 South Rampart Pharma.